Back to Search
Start Over
Blinatumomab is Safe and Effective in Relapsed and MRD Positive B-ALL CD19+ Patients: the Bologna Compassionate Program Experience.
- Source :
- Clinical Lymphoma, Myeloma & Leukemia; Sep2016 Supplement 2, Vol. 16, pS14-S15, 1p
- Publication Year :
- 2016
Details
- Language :
- English
- ISSN :
- 21522650
- Volume :
- 16
- Database :
- Complementary Index
- Journal :
- Clinical Lymphoma, Myeloma & Leukemia
- Publication Type :
- Academic Journal
- Accession number :
- 117709040
- Full Text :
- https://doi.org/10.1016/j.clml.2016.07.022